EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PEPTIDE IDR-1002 REGULATES THE ANTIOXIDANT AND ANTI-INFLAMMATORY RESPONSES BY ACTIVATING THE KEAP1-NRF2 SIGNALING PATHWAY

Marco Antonio Romero-Durán, María Cristina Maldonado-Pichardo, Jose Manuel Perez-Aguilar, Victor Manuel Baizabal Aguirre

F1000Research · 06.02.2026 · 15 · 204

DOI: 10.12688/f1000research.177148.1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift F1000Research, online erschienen am 06.02.2026. Verfasst von Marco Antonio Romero-Durán und 3 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Secretaría de Ciencia, Humanidades, Tecnología e Innovación, Coordinación de la Investigación Científica, Universidad Michoacana de San Nicolás de Hidalgo, Instituto de Ciencia Tecnología e Innovación.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Oxidative stress and inflammation are mutually reinforcing physiological processes. The transcription factor Nrf2 (Nuclear factor erythroid 2-related factor 2) acts as the master regulator of redox homeostasis and anti-inflammatory signaling. To overcome the off-target limitations of conventional electrophilic Nrf2 activators, this study investigates selective peptide-based modulators. We present data indicating that an innate defense regulator (IDR)-1002 peptide is able to activate the Nrf2-mediated antioxidant response and mitigate inflammation in an endothelial cell model.

Methods

We first screened several IDR peptides IDR-1 (Lys-Ser-Arg-Ile-Val-Pro-Ala-Ile-Pro-Val-Ser-Leu-Leu), IDR-1018 (Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg), HH2 (Val-Gln-Leu-Arg-Ile-Arg-Val-Ala-Val-Ile-Arg-Ala) and IDR-1002 (Val-Gln-Arg-Trp-Leu-Ile-Val-Trp-Arg-Ile-Arg-Lys) for their ability to induce Nrf2 nuclear translocation in HEK293 and bovine endothelial cells (BEC) via Western blot and ELISA. Transcriptional activity was assessed in HepG2 cells using an ARE (Antioxidant Response Element)-luciferase reporter assay to determine the EC 50 . Downstream expression of antioxidant enzymes, including HO-1 (Heme Oxygenase-1), NQO1 (NAD(P)H:quinone oxidoreductase 1), and GCLM (Glutamate-Cysteine Ligase Modifier Subunit), was quantified by ELISA. GST (Glutathione S-Transferase) activity induced by IDR-1002 was measured using a CDNB-GSH conjugation assay. Finally, the functional capacity to reduce H 2 O 2 -induced ROS (Reactive Oxygen Species) and TNF-stimulated inflammation was measured in BECs.

Results

Among the tested peptides, IDR-1002 induced the most potent concentration-dependent nuclear translocation of Nrf2 in both cell lines. IDR-1002 activated ARE-dependent transcription with an EC 50 of 18.57 μM. This activation led to a significant time-dependent increase in HO-1, NQO1, and GCLM protein levels, alongside enhanced GST activity. Functionally, IDR-1002 pre-treatment resulted in a dose-dependent reduction of intracellular ROS (up to 5.4-fold at 50 μM) and a significant decrease in TNF-α expression in stimulated BECs.

Conclusions

IDR-1002 acts as a potent dual-function regulator that simultaneously activates the Nrf2 antioxidant response and inhibits NF-κB-mediated inflammation. These findings highlight IDR-1002 as a promising therapeutic candidate for chronic diseases characterized by the interplay between oxidative stress and inflammation.

Förderung

  • Secretaría de Ciencia, Humanidades, Tecnología e Innovación
  • Coordinación de la Investigación Científica, Universidad Michoacana de San Nicolás de Hidalgo
  • Instituto de Ciencia Tecnología e Innovación

Zitieren

APA

Romero-Durán, M. A., Maldonado-Pichardo, M. C., Perez-Aguilar, J. M., & Aguirre, V. M. B. (2026). PEPTIDE IDR-1002 REGULATES THE ANTIOXIDANT AND ANTI-INFLAMMATORY RESPONSES BY ACTIVATING THE KEAP1-NRF2 SIGNALING PATHWAY. F1000Research, 15, 204. https://doi.org/10.12688/f1000research.177148.1

Vancouver

Romero-Durán MA, Maldonado-Pichardo MC, Perez-Aguilar JM, Aguirre VMB. PEPTIDE IDR-1002 REGULATES THE ANTIOXIDANT AND ANTI-INFLAMMATORY RESPONSES BY ACTIVATING THE KEAP1-NRF2 SIGNALING PATHWAY. F1000Research. 2026;15:204. doi:10.12688/f1000research.177148.1

BibTeX
@article{RomeroDurn2026,
  author = {Romero-Durán, Marco Antonio and Maldonado-Pichardo, María Cristina and Perez-Aguilar, Jose Manuel and Aguirre, Victor Manuel Baizabal},
  title = {PEPTIDE IDR-1002 REGULATES THE ANTIOXIDANT AND ANTI-INFLAMMATORY RESPONSES BY ACTIVATING THE KEAP1-NRF2 SIGNALING PATHWAY},
  journal = {F1000Research},
  year = {2026},
  volume = {15},
  pages = {204},
  doi = {10.12688/f1000research.177148.1}
}
Kostenlos starten →